Predictive and prognostic value of genetic aberrations of EGFR-TKI treatment: a real-world analysis of EGFR-mutant non-small cell lung cancer
This study identified key biomarkers associated with the efficacy of EGFR-TKIs and survival in patients with <i>EGFRm</i> NSCLC, thereby providing new insights for personalized therapeutic strategies based on genetic risk stratification.
Authors
- Fufeng Wang (ORCID: https://orcid.org/0000-0002-8933-4909)
- Xin Lv (ORCID: https://orcid.org/0000-0002-3352-7162)
- Jiani C. Yin (ORCID: https://orcid.org/0000-0002-9523-1930)
- Chunhong He (ORCID: https://orcid.org/0000-0003-0997-0583)
- Ye Liu (ORCID: https://orcid.org/0000-0002-1901-669X)
- Min Wei (ORCID: https://orcid.org/0000-0001-9629-6413)
- Fangjun Chen (ORCID: https://orcid.org/0000-0003-3509-6308)
- Yuxin Cheng (ORCID: https://orcid.org/0000-0002-3030-588X)
- Lifeng Wang (ORCID: https://orcid.org/0000-0002-9209-1004)
- Shu Su (ORCID: https://orcid.org/0000-0001-8704-9752)
Institutions
- Nanjing University of Chinese Medicine (CN)
- Nanjing Drum Tower Hospital (CN)
- Genesee Community College (US)
Publication Details
- Journal
- Journal of Thoracic Disease
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/jtd-2024-2159
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 1.52